Oregon Health Authority Health Evidence Review Commission Written Public Comments Feb 2026
Insulet Omnipod Coverage Considered for OHP Members
Trusted by teams at
Description
Public comments to the Oregon Health Authority suggested that Insulet Corporation's Omnipod Insulin Delivery System be considered for coverage as a disposable insulin pump option for Type 1 diabetes. No formal procurement action appears in the comments, but vendor inclusion is under discussion.
Contract Details
Vendor
INSULET CORPORATION
Agency
Oregon HA | Health Evidence Review Commission, OR
Contract Type
EQUIPMENT
Document Date
February 5, 2026
More from INSULET CORPORATION
Related Contracts
Health Evidence Review Commission and Value-based Benefits Subcommittee Meeting Agenda March 19, 2026
DISCUSSEDHealth Evidence Review Commission and Value-based Benefits Subcommittee Meeting Agenda March 19, 2026
DISCUSSSEDOregon Health Authority Health Evidence Review Commission Written Public Comments Feb 2026
DISCUSSEDMore from Oregon HA | Health Evidence Review Commission
Oregon HA Health Evidence Review Commission Report Acellular Scaffold Implant March 2026
Oregon Health Authority Public Comments March 2026
Health Evidence Review Commission and Value-based Benefits Subcommittee Meeting Agenda March 19, 2026
Health Evidence Review Commission and Value-based Benefits Subcommittee Meeting Agenda March 19, 2026
Health Evidence Review Commission and Value-based Benefits Subcommittee Meeting Agenda March 19, 2026
Want to learn more?
Get alerts on contract renewals, new awards, and vendor activity.
Bring us your territory.
We'll show you what is forming.
See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.